{
  "id": 12417112,
  "title": "Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial",
  "url": "https://urgent.news/2026/10/06/dual-acting-drug-from-abbvie-genmab-scores-in-frontline-lymphoma-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T15:42:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/abbvie-genmab-epkinly-dlbcl-epcore-study-results/832241/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The better-than-expected results could make Epkinly the new “undisputed” treatment standard in newly diagnosed DLBCL, according to one analyst.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "AbbVie, Genmab trot out first-line DLBCL win for Epkinly in challenge to Polivy",
        "url": "https://urgent.news/2026/10/06/abbvie-genmab-trot-out-first-line-dlbcl-win-for-epkinly-in-challenge",
        "published": "2026-10-06T11:05:14.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}